Rapid and automated interpretation of CRISPR-Cas13-based lateral flow assay test results using machine learning
{{output}}
CRISPR-Cas-based lateral flow assays (LFAs) have emerged as a promising diagnostic tool for ultrasensitive detection of nucleic acids, offering improved speed, simplicity and cost-effectiveness compared to polymerase chain reaction (PCR)-based assays. However,... ...
